Trial intelligence / Profile preview

Acute IV Magnesium in Stable COPD

NCT00500864Phase 2Completed

Sponsor
Universidade de São Paulo
Start
Aug 2004
Primary completion
Nov 2007
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial of magnesium sulfate in chronic obstructive pulmonary disease (COPD) (2 arms), sponsored by Universidade de São Paulo. Primary endpoints: Forced Vital Capacity, Forced Expiratory Volume in 1 second and 4 more. Started Aug 2004; status: completed.

02

Drugs

magnesium sulfate
03

Conditions

chronic obstructive pulmonary disease (COPD)

Beyond the preview

Go deeper on NCT00500864.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00500864.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call